Landos Biopharma (LABP) Institutional Ownership → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free LABP Stock Alerts $22.35 +0.17 (+0.77%) (As of 04/25/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Landos Biopharma (NASDAQ:LABP)CurrentInstitutional OwnershipPercentage49.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.07MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$56.07M Get LABP Insider Trade Alerts Want to know when executives and insiders are buying or selling Landos Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LABP Institutional Buying and Selling by Quarter Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). Landos Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/17/2024 Deltec Asset Management LLC50,000$1.07M0.2%N/A1.603% 8/24/2023Perceptive Advisors LLC1,486,991$6.26M0.2%-90.0%47.660% 11/14/2022RTW Investments LP3,975,722$2.58M0.1%-7.0%9.876% 11/1/2022OUP Management Co. LLC1,237,667$804K1.3%-23.3%3.074% 10/31/2022Green Square Capital Advisors LLC84,500$55K0.0%N/A0.210% 7/19/2022OUP Management Co. LLC1,612,764$1.17M1.6%-11.7%4.006% Get the Latest News and Ratings for LABP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Landos Biopharma and its competitors with MarketBeat's FREE daily newsletter. 3/3/2022Walleye Capital LLC105,208$505K0.0%N/A0.262% 2/10/2022Acadian Asset Management LLC8,274$39K0.0%N/A0.021% 2/3/2022OUP Management Co. LLC1,827,478$8.77M4.0%N/A4.555% 11/12/2021Geode Capital Management LLC112,933$1.65M0.0%-11.4%0.282% 11/12/2021Botty Investors LLC128,750$1.88M0.6%+4.9%0.321% 11/9/2021BlackRock Inc.233,616$3.41M0.0%-20.6%0.582% 11/4/2021Deutsche Bank AG2,693$39K0.0%-30.0%0.007% 11/2/2021 Cambridge Investment Research Advisors Inc.18,831$275K0.0%N/A0.047% 11/2/2021New York State Common Retirement Fund2,756$40K0.0%-62.5%0.007% 11/2/2021Allworth Financial LP5,286$77K0.0%N/A0.013% 10/22/2021Strs Ohio11,400$166K0.0%+660.0%0.028% 8/17/2021Logos Global Management LP899,106$10.39M0.9%+22.5%2.241% 8/16/2021Tudor Investment Corp Et Al17,793$206K0.0%-71.3%0.044% 8/16/2021State Street Corp92,367$1.07M0.0%+88.1%0.230% 8/13/2021Botty Investors LLC122,781$1.42M0.5%+26.0%0.306% 8/13/2021Geode Capital Management LLC127,518$1.47M0.0%+15.3%0.318% 8/13/2021Vanguard Group Inc.305,185$3.52M0.0%+61.9%0.761% 8/11/2021Bank of New York Mellon Corp14,029$162K0.0%+37.8%0.035% 8/11/2021BlackRock Inc.294,043$3.40M0.0%+14.7%0.733% 5/27/2021Davidson Kempner Capital Management LP50,000$480K0.0%N/A0.125% 5/19/2021Logos Global Management LP734,000$7.07M0.7%N/A1.830% 5/19/2021Squarepoint Ops LLC15,361$148K0.0%N/A0.038% 5/18/2021Zimmer Partners LP90,100$868K0.0%N/A0.225% 5/18/2021Tudor Investment Corp Et Al61,899$596K0.0%N/A0.154% 5/18/2021Orbimed Advisors LLC681,000$6.56M0.1%N/A1.697% 5/18/2021Davidson Kempner Capital Management LP50,000$480K0.0%N/A0.125% 5/18/2021Old Well Partners LLC18,316$176K0.1%N/A0.046% 5/18/2021California State Teachers Retirement System9,518$92K0.0%N/A0.024% 5/17/2021Deerfield Management Company L.P. Series C450,000$4.33M0.1%N/A1.122% 5/17/2021Perceptive Advisors LLC17,960,839$159.69M2.0%N/A44.770% 5/17/2021Woodline Partners LP213,335$2.05M0.0%N/A0.532% 5/17/2021Caas Capital Management LP40,000$385K0.0%N/A0.100% 5/17/2021Nuveen Asset Management LLC10,219$98K0.0%N/A0.025% 5/17/2021Sphera Funds Management LTD.70,000$674K0.1%N/A0.174% “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars).5/14/2021Laurion Capital Management LP10,000$96K0.0%N/A0.025% 5/14/2021RTW Investments LP4,275,722$38.33M0.6%N/A10.658% 5/14/2021Monashee Investment Management LLC91,309$879K0.1%N/A0.228% 5/13/2021Bank of New York Mellon Corp10,182$98K0.0%N/A0.025% 5/13/2021Botty Investors LLC97,477$939K0.3%N/A0.243% 5/12/2021Northern Trust Corp74,359$716K0.0%N/A0.185% 5/12/2021Geode Capital Management LLC110,559$1.06M0.0%N/A0.276% 5/12/2021Ensign Peak Advisors Inc125,000$1.20M0.0%N/A0.312% 5/12/2021JPMorgan Chase & Co.375,021$3.61M0.0%N/A0.935% 5/11/2021Teacher Retirement System of Texas10,000$96K0.0%N/A0.025% 5/11/2021New York State Common Retirement Fund7,300$70K0.0%N/A0.018% 5/7/2021BlackRock Inc.256,290$2.47M0.0%N/A0.639% 5/7/2021American International Group Inc.3,677$35K0.0%N/A0.009% (Data available from 1/1/2016 forward) LABP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LABP shares? During the previous two years, the following institutional investors and hedge funds held shares of Landos Biopharma shares: Perceptive Advisors LLC ($6.26M), RTW Investments LP ($2.58M), Deltec Asset Management LLC ($1.07M), and OUP Management Co. LLC ($804K), Green Square Capital Advisors LLC ($55K).Learn more on LABP's institutional investors. What percentage of Landos Biopharma stock is owned by institutional investors? 49.06% of Landos Biopharma stock is owned by institutional investors. Learn more on LABP's institutional investor holdings. Which institutional investors have been buying Landos Biopharma stock? The following institutional investors have purchased Landos Biopharma stock in the last 24 months: Green Square Capital Advisors LLC ($84.50K), and Deltec Asset Management LLC ($50K). How much institutional buying is happening at Landos Biopharma? Institutional investors have bought a total of 134,500 shares in the last 24 months. This purchase volume represents approximately $1.62M in transactions. Which Landos Biopharma major shareholders have been selling company stock? The following institutional investors have sold Landos Biopharma stock in the last 24 months: Perceptive Advisors LLC ($13.38M), OUP Management Co. LLC ($589.81K), and RTW Investments LP ($300K). How much institutional selling is happening at Landos Biopharma? Institutional investors have sold a total of 14,272,735 shares in the last 24 months. This volume of shares sold represents approximately $62.03M in transactions. Related Companies: Anebulo Pharmaceuticals Major Shareholders Carisma Therapeutics Major Shareholders Viveon Health Acquisition Major Shareholders Rallybio Major Shareholders Assembly Biosciences Major Shareholders Cue Biopharma Major Shareholders MediciNova Major Shareholders vTv Therapeutics Major Shareholders Corvus Pharmaceuticals Major Shareholders YS Biopharma Major Shareholders This page (NASDAQ:LABP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Landos Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
